The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

Danone does not anticipate any tightening of regulations in the wake of the formula recalls as it pointed to a negligible impact on sales.

By Alexander Marrow LONDON, Feb 18 (Reuters) - Nestle and Danone face investor pressure to spell out the financial impact of their biggest infant formula recalls in recent history, and show they have ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Stymied in its takeover bid for Lifeway Foods, minority ...

French firms Danone and Nestlé saw a continued plunge in their share prices on Wednesday after a safety crisis involving baby formula. At around midday in Europe, Danone shares were down 0.48%, while ...

Fourth-quarter sales topped estimates as protein demand strengthened, while infant formula recalls could trim first-quarter net sales by 0.5% to 1%.

Danone is undergoing a transformation with positive results, showing potential for a 13-16% annualized RoR. Danone remains an underperforming stock with a 2x variance compared to the market. Despite ...

In order to improve its operational efficiency, dairy major Danone has enlisted Microsoft. The two companies will collaborate to implement AI in Danone’s systems. Artificial Intelligence (AI) is ...

This week, Danone cut the ribbon on its OneBiome Laboratory in Paris-Saclay. The facility, housed within its International Research and Innovation Centre, is dedicated to one of the most complex areas ...